Skip to main content
SpringerLink
Log in

Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goals

To evaluate the effectiveness and side effects of intrapericardial administration of cisplatin in prevention of recurrent malignant pericardial effusion.

Patients and methods

Forty-six patients (33 men, 13 women; mean age 55.6±10.5 years) entered this study. The diagnosis of malignancy was based upon histological examination of samples from primary tumor. The majority of patients suffered from a neoplasm localized in the thorax (41 out of 46 patients; 89%). In 35 cases, pericardiocentesis, and in 11 cases, video-assisted thoracoscopic surgery (VATS) of pericardium was performed. Malignant etiology of pericardial fluid was confirmed by cytological examination, histology being obtained by VATS pericardial biopsy or by echocardiography (ECG). If daily drainage of pericardial fluid observed during 5–7 days exceeded 50 ml, cisplatin was instilled according to one of three regimens: (1) 10 mg of cisplatin dissolved in 20 ml of normal saline administered over 5 min during 5 consecutive days directly into the pericardial space (39 patients); (2) 50 mg of cisplatin dissolved in 100 ml of normal saline administered during 30 min (six patients); and (3) 20 mg of cisplatin dissolved in 40 ml of normal saline administered over 10 min during 5 consecutive days (one patient). Treatment was considered as successful when recurrence of symptoms of large pericardial effusion was not observed in ECG and other interventions directed to the pericardium were not required. Efficacy of investigated treatment was assessed also in the group of patients with survival longer than 30 days. Safety of treatment was assessed in the whole group of patients.

Results

Because of advanced malignancy eight out of 46 patients (17.4%) survived less than 30 days. Thirty-eight out of 46 cases (82.6%) survived more than 30 days. Positive effect of intrapericardial treatment with cisplatin was achieved in 43 out of 46 patients (93.5%) in the entire investigated group and in 35 out of 38 patients (92%) who survived more than 30 days. In the subgroup of patients with non-small cell lung cancer (NSCLC) and survival longer than 30 days, high efficacy was documented (29 out of 31 cases; 93.5%). Median survival time in the group of 38 patients who survived more than 30 days was 102.5 days. Atrial fibrillation due to cisplatin administration was observed in seven out of 46 patients (15.2%). Sclerosis of the pericardial space without symptoms of constriction occurred in five out of 46 cases (10.9%).

Conclusions

Cisplatin administered directly into the pericardial space is a very effective and relatively safe method of treatment of recurrent malignant pericardial effusion, especially in the course of NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Colleoni M, Martinelli G, Beretta F et al (1998) Intracavitary chemotherapy with thiotepa in malignant pericardial effusion: an active and well tolerated regimen. J Clin Oncol 16:2371–2376

    CAS  PubMed  Google Scholar 

  2. DeCamp MM, Mentzer SJ, Swanson SJ et al (1997) Malignant effusive disease of pleura and pericardium. Chest 112 [Suppl]: 291–295

  3. Fagan SM, Chan KI (1999) Pericardiocentesis. Blind no more! Chest 116:275–276

  4. Girardi LN, Ginsberg RJ, Burt ME (1997) Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusion. Ann Thorac Surg 64:1422–1428

    Article  CAS  PubMed  Google Scholar 

  5. Klatt EC, Heitz DR (1990) Cardiac metastases. Cancer 65:1456–1459

    CAS  PubMed  Google Scholar 

  6. Lashevsky I, Ben Yosef R, Rinkevich D et al (1996) Intrapericardial minocycline sclerosis for malignant pericardial effusion. Chest 109:1452–1454

    CAS  PubMed  Google Scholar 

  7. Liu G, Crump M, Goss PE et al (1996) Prospective comparison of the sclerosis agents doxacycline and bleomycin for the primary mangement of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 14:3141–3147

    CAS  PubMed  Google Scholar 

  8. Maghfoor I, Doll DC, Yarbro JW. (2000) Effusions. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds) Clinical oncology. Churchill Livingstone, New York, pp 922–949

  9. Maher EA, Shepherd FA, Todd TJR (1996) Pericardial sclerosis as the primary management of malignant effusion and cardiac tamponade. J Thorac Cardiovasc Surg 112:637–643

    CAS  PubMed  Google Scholar 

  10. Maisch B, Ristic AD,Pankuweit S et al (2002) Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23:1625–1631

    Article  CAS  PubMed  Google Scholar 

  11. Markiewicz W, Lashevsky I, Rnkevich D et al (1998) The acute effect of minocycline sclerosis on the pericardium. Experimental and clinical findings. Chest 113; 861–866

    Google Scholar 

  12. Martinoni A, Cipolla CM, Civelli M et al (2000) Intrapericardial treatment of neoplastic pericardial effusion. Herz 25:787–793

    CAS  PubMed  Google Scholar 

  13. Press OW, Livingston R (1987) Management of malignant pericardial effusion and tamponade. JAMA 257:1088–1092

    Article  CAS  PubMed  Google Scholar 

  14. Shepherd FA, Morgan C, Evans WK et al (1987) Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 60:1161–1166

    CAS  PubMed  Google Scholar 

  15. Soler-Soler J, Merce J, Sagrista-Sauleda J (1998) Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade? Am J Med 105:106–109

    Article  PubMed  Google Scholar 

  16. Spodick DH (1997) Neoplastic pericardial disease. In: Spodick DH (ed) The pericardium: A comprehensive textbook. Marcel Dekker, New York, pp 301–313

  17. Susini G, Pepi M, Sisillo E et al (1993) Percutaneous pericardiocentesis versus subxiphoid pericardiotomy in cardiac tamponade due to postoperative pericardial effusion. J. Cardiothorac Vasc Anesthes 7:178–183

    CAS  Google Scholar 

  18. Tamura A, Matsubara O, Yoshimura N et al (1992) Cardiac matastases of lung cancer. Cancer 70:437–442

    CAS  PubMed  Google Scholar 

  19. Thurber DL, Edwards JE, Achor RWP (1962) Secondary malignant tumors of the pericardium. Circulation 26:228–241

    CAS  Google Scholar 

  20. Tomkowski WZ, Filipecki S (1997) Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung. Monaldi Arch Chest Dis 52, 221–224

    Google Scholar 

  21. Tomkowski WZ, Filipecki S (1997) Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in course of lung cancer. Lung Cancer 16:215–222

    Article  CAS  PubMed  Google Scholar 

  22. Tomkowski W, Szturmowicz M, Fijalkowska A et al (1997) New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 5:64–66

    Article  CAS  PubMed  Google Scholar 

  23. Tondini M, Rocco G, Bianchi C (1995) Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis 50:86–88

    CAS  PubMed  Google Scholar 

  24. Tsang TSM, Freeman WK, Sinak LJ, Seward JB et al (1998) Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc 73:647–652

    CAS  PubMed  Google Scholar 

  25. Tsang TSM, Seward JB, Barnes ME (2000) Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 75:248–253

    CAS  PubMed  Google Scholar 

  26. Vaitkus PT, Herrmann HC, LeWinter MM (1994) Treatment of malignant pericardial effusion. JAMA 272:59–64

    Article  CAS  PubMed  Google Scholar 

  27. Yano T, Yokoyama H, Inoue T et al (1994) A simple technique to manage malignant pericardial effusion with local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 51:507–509

    CAS  PubMed  Google Scholar 

  28. Zwischenberger JB, Sanker AB, Lee R. (2000) Malignant pericardial effusion. In: Pass HJ, Mitchell JB, Johnson DH, Turrisi AT, Minna JD (eds) Lung cancer. Principles and practice. Lippincott, Philadelphia, pp 1038–1046

Download references

Author information

Authors and Affiliations

  1. Intensive Care Unit, National Tuberculosis and Lung Diseases Research Institute, Płocka 26, 01–138, Warsaw, Poland

    Witold Zbyszek Tomkowski, Joanna Wiśniewska, Paweł Kuca & Janusz Burakowski

  2. Department of Chest Medicine, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

    Monika Szturmowicz, Jarosław Kober & Anna Fijałkowska

Authors
  1. Witold Zbyszek Tomkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna Wiśniewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monika Szturmowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paweł Kuca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Janusz Burakowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jarosław Kober
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anna Fijałkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Witold Zbyszek Tomkowski.

Additional information

Work was performed at the National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. Research was performed without financial support. No author is involved with organizations with financial interest in the subject matter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomkowski, W.Z., Wiśniewska, J., Szturmowicz, M. et al. Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer 12, 53–57 (2004). https://doi.org/10.1007/s00520-003-0533-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-003-0533-x

Keywords

Search

Navigation